1. Javed F, Romanos GE. Impact of diabetes mellitus and
glycemic control on the osseointegration of dental implants:
a systematic literature review. J Periodontol. 2009;
80:1719–1730.
2. Preeti AK, Manish K. Rupal J. Shah. Rehabilitative
Considerations for Dental Implantsin the Diabetic Patient.
J Indian Prostho dont Soc 13:175–183.
3. Preshaw PM. Host response modulation in periodontics.
Periodontology 2000. 2008; 48: 92-110.
4. Isoda K, Ayukawa Y, Tsukiyama Y, Sogo M, Matsushita
Y, Koyano K. Relationship between the bone densities estimated
by cone-beam computed tomography and the primary
stability of dental implants. Clin Oral Implants Res
2012; 23:832-836.
5. González-Martín O, Lee EA, Veltri M: CBCT fractal dimension
changes at the apex of immediate implants placed
using undersized drilling. Clin. Oral Implants Res 2012;
23: 954–95.
6. Hsu JT, Chang HW, Huang HL, Yu JH, Li YF, Tu MG:
Bone density changes around teeth during orthodontic
treatment. Clin Oral Investig 2011; 15:511-519
7.
Monje A, Monje F, Gonzalez-Garcı R, GalindoMoreno P,
Rodriguez-Salvanes F, Wang HL. Comparison between
microcomputed tomography and cone-beam computed
tomography radiologic bone to assess atrophic posterior
maxilla density and microarchitecture. Clin Oral Implants
Res 2014; 25: 723-728.
8. Hasan I, Dominiak M, Blaszczyszyn A, Bourauel C,
Gedrange T, Heinemann F. Radiographic evaluation of
bone density around immediately loaded implants. Ann
Anat 2015; 199:52-57.
9. Kholsa S. Minireview: the Opg/Rankl/Rank system.
Endocrinology 2001; 142: 5050–5055.
10. Abramson, J. H. The Cornell medical index as an epidemiological
tool, Am J Pub H and the Nat H 1966; 56:
287–298.
11. Caton J, Ryan ME. Clinical studies on the management of
periodontal diseases utilizing subantimicrobial dose doxycycline
(SDD). Pharmacol Res .2011; 63: 114-120.
12. Busenlechner D, Furhauser R, Haas R, Watzek G, Mailath
G, Pommer B. Long-term implant success at the Academy
for Oral Implantology: 8-year follow-up and risk factor
analysis. J Periodontal Implant Sci 2014; 44:102–8.
13.
Lambert P, Morris H, Ochi S: The influence of 0.12%
chlorhexidine digluconate rinses on the incidence of infectious
complications and implant success. J Oral Maxillofac
Surg 1997; 55:25-30.
14. Yassir Elkhidir, Sun Wei, Li Suyang, Mengqing Xie and
Cheng Yang. Feasibility of CBCT in Evaluating Bone
Density of Dental Implant Placement Sites. RRJDS. 2017;
5:87-91
15
Schwartz A. Diabetes mellitus: does it affect bone? CTI
2003; 73:515-9.
16. Oates T, Huynh-Ba G, Vargas A, Alexander P, Feine J. A
critical review of diabetes, glycemic control, and dental
implant therapy. Clin Oral Implants Res 2013; 24:117-27.
17. Olson JW, Shernoff AF, Tarlow JL, Colwell JA, Scheetz
JP, Bingham SF. Dental endosseous implant assessments
in a type 2 diabetic population: A prospective study. Int J
Oral Maxillofac Implants 2000; 15:811-818.
18. Peled M, Ardekian L, Tagger-Green N, Gutmacher Z,
Machtei EE. Dental implants in patients with type 2
diabetes mellitus: A clinical study. Implant Dent 2003;
12:116-122.
19. Casap N, Nimri S, Ziv E, Sela J, Samuni Y. Type 2 diabetes
has minimal effect on osseointegration of titanium
implants in Psammomys obesus. Clin Oral Implants Res
2008; 19:458-64.
20.
Balshi SF, Wolfinger GJ, Balshi TJ. An examination of
immediately loaded dental implant stability in the diabetic
patient using resonance frequency analysis (RFA).
Quintessence Int 2007; 38:271-9.
21. Tawil G, Younan R, Azar P, Sleilati G. Conventional and
advanced implant treatment in the type II diabetic patient:
surgical protocol and long-term clinical results. Int J Oral
Maxillofac Implants 2008; 23:744–52.
22. Morris HF, Ochi S, Winkler S. Implant survival in patients
with type 2 diabetes. Ann Periodontol 2000; 5:157-65.
23. Mccracken MS, Aponte-Wesson R, Chavali R, Lemons
JE McCracken. Bone associated with implants in diabetic
and insulin-treated rats. Clin Oral Implants Res 2006; 17:
495-500.
24. Hasegawa H, Ozawa S, Hashimoto K, Takeichi T, Ogawa T.
Type 2 diabetes impairs implant osseointegration capacity
in rats. Int J Oral Maxillofac Implants 2008; 23:237-246.
25. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host
modulation with antiproteinase, anti- inflammatory, and
bone-sparing agents. A systematic review. Ann Periodontol
2003; 8:12-37.
26. Preshaw PM, Hefti AF, Novak MJ. Subantimicrobial
dose doxycycline enhances the efficacy of scaling and
root planing in chronic periodontitis: a multicenter trial. J
Periodontol 2004;75:1068-76.
27. Khoury SB, Thomas L, Walters JD, Sheridan JF,
Leblebicioglu B. Early wound healing following one-stage
dental implant placement with and without antibiotic prophylaxis:
a pilot study. J Periodontol 2008; 79:1904–1912.
28. Alissa R, Sakka S, Oliver R, Horner K, Esposito M,
Worthington HV, Coulthard P. Influence of ibuprofen
on bone healing around dental implants: a randomized
double-blind placebo controlled clinical study. Eur J Oral
Implantol 2009; 2:185–199.
29. Waasdorp JA, Evian CI, Mandracchia M. Immediate
placement of implants into infected sites: a systematic
review of the literature. J. Periodontol 2010; 81:801–806.
30.
Barunawarty Y. Assessment of the increased calcification
of jaw bone with CT-Scan after dental implant placement.
Imaging Sci Dent 2011; 41: 59- 62.
31. Golub L, Lee H-M, Greenwald R, Ryan M, Sorsa T, Salo
T. A matrix metalloproteinase inhibitor reduces bone-type
collagen degradation fragments and specific collagenases
in gingival crevicular fluid during adult periodontitis. IR
1997; 46:310-9.
32. Gomes PS, Fernandes MH. Effect of therapeutic levels
of doxycycline and minocycline in the proliferation and
differentiation of human bone marrow osteoblastic cells.
AOB 2007; 52:251-9.
33. Almazin SM, Dziak R, Andreana S. The effect of
doxycycline hyclate, chlorhexidine gluconate, and
minocycline hydrochloride on osteoblastic proliferation
and differentiation in vitro. J Periodontol 2009; 80: 999–
1005.
34. Eglence A, Colterjohn N, Duivenvoorden WC, Ghert M,
Singh G. Effect of bone morphogenetic protein-2 and
doxycycline on the differentiation of osteoprogenitors
from human femoral bone. Open Bone J. 2009; 1:1-7.
35. Shahabooei M, Razavi SM, Minaiyan M. A
histomorphometric study of the effect of doxycycline and
erythromycin on bone formation in dental alveolar socket
of rat. Adv Biomed Res 2015; 4:71.
36. Lin Ding, Peng Zhang, Xin Wang, Jia Hao, Kazuhiro Aoki,
Shinji Kuroda, Shohei Kasugai Effect of doxycyclinetreated
hydroxyapatite surface on bone apposition: A
histomophometric study in murine maxillae. DMJ 2017;
11: 1- 9.
37. Yiming Liu, Jing Hu, Biao Liu, Xiliang Jiang, Yunfeng
Li. peri-implant bone mass and improved trabecular
microarchitecture. The effect of osteoprotegerin on
implant osseointegration in ovariectomized rats. Arch Med
Sci 2017; 13, 2: 489–495.
38. Sunitha RV, Ramakrishnan T, Kumar S, Emmadi P. Soft
tissue preservation and crestal bone loss around singletooth
implants. J Oral Implantol 2008; 34:223-229.
39. PriyanKa Boora, Manu rathee, MohaneeSh Bhoria. Effect
of Platelet Rich Fibrin on Peri- implant Soft Tissue and
Crestal Bone. JCDR 2015; 9: 18-21.
40. Cavallaro JS Jr. Implant survival and radiographic analysis
of proximal bone levels surrounding a contemporary
dental implant. Implant Dent 2011; 20: 146-5.
41. Lee DW, Choi YS, Park KH, Kim CS, Moon IS. Effect of
microthread on the maintenance of marginal bone level:
a 3-year prospective study. Clin Oral Implants Res 2007;
18:465-70.
42. Cochran DL, Nummikoski V, Schoolfeld JD, Jones AA,
Oates TW. A prospective multicenter 5-year radiographic
evaluation of crestal bone levels over time in 596 dental
implants placed in 192 patients. J Periodontol 2009;
80:725-33.
43. Choi DH, Moon IS. Effects of sub-antimicrobial dose
doxycycline therapy on crevicular fluid MMP-8 and
gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic
periodontitis. J Periodont Res 2004; 39: 20-26.
44. Kinugawa S, Koide M, Kobayashi Y. Tetracyclines convert
the osteoclasticdifferentiation pathway of progenitor cells
to produce dendritic cell-like cells. J Immunol 2012; 188:
1772–1781.
45. Nurdan O, Ceren G. Chemical inhibition of matrix
metalloproteinases for periodontal treatment. Antiinflamm
Antiallergy Agents Med Chem 2015; 2: 21-26.
46. Bezerra MM, Brito GA, Ribeiro RA. Low-dose
doxycycline prevents inflammatory bone resorption in
rats. Braz J Med Biol Res 2002; 35: 613–616.
47. Holmes SG, Still K, Buttle DJ, Bishop NJ. Chemically
modified tetracyclines act through multiple mechanisms
directly on osteoclast precursors. Bone 2004; 35:471-8.
48. Zhang C, Tang TT, Ren WP. Inhibiting wear particlesinduced
osteolysis with doxycycline. Acta Pharmacol Sin
2007; 28:1603–1610.
.